Health Care Provider Adherence to Surgical Guidelines for Risk-Reducing Salpingo-Oophorectomy.
Adult
Fallopian Tube Neoplasms
/ genetics
Fallopian Tubes
/ surgery
Female
Genes, BRCA1
Genes, BRCA2
Guideline Adherence
/ statistics & numerical data
Gynecology
/ standards
Humans
Middle Aged
Obstetrics
/ standards
Ovarian Neoplasms
/ genetics
Prophylactic Surgical Procedures
/ standards
Retrospective Studies
Salpingo-oophorectomy
/ standards
Surgical Oncology
/ standards
Journal
Obstetrics and gynecology
ISSN: 1873-233X
Titre abrégé: Obstet Gynecol
Pays: United States
ID NLM: 0401101
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
pubmed:
14
8
2019
medline:
24
3
2020
entrez:
13
8
2019
Statut:
ppublish
Résumé
To evaluate health care provider adherence to the surgical protocol endorsed by the National Comprehensive Cancer Network and the American College of Obstetricians and Gynecologists at the time of risk-reducing salpingo-oophorectomy and compare adherence between gynecologic oncologists and obstetrician-gynecologists (ob-gyns). In this multicenter retrospective cohort study, women were included if they had a pathogenic BRCA mutation and underwent risk-reducing salpingo-oophorectomy between 2011 and 2017. Adherence was defined as completing all of the following: collection of washings, complete resection of the fallopian tube, and performing the Sectioning and Extensively Examining the Fimbriated End (SEE-FIM) pathologic protocol. Of 290 patients who met inclusion criteria, 160 patients were treated by 18 gynecologic oncologists and 130 patients by 75 ob-gyns. Surgery was performed at 10 different hospitals throughout a single metropolitan area. Demographic and clinical characteristics were similar between groups. Overall, 199 cases (69%) were adherent to the surgical protocol. Gynecologic oncologists were more than twice as likely to fully adhere to the full surgical protocol as ob-gyns (91% vs 41%, P<.01). Specifically, gynecologic oncologists were more likely to resect the entire tube (99% vs 95%, P=.03), to have followed the SEE-FIM protocol (98% vs 82%, P<.01), and collect washings (94% vs 49%, P<.01). Complication rates did not differ between groups. Occult neoplasia was diagnosed in 11 patients (3.8%). The incidence of occult neoplasia was 6.3% in gynecologic oncology patients and 0.8% in obstetrics and gynecology patients (P=.03). Despite clear surgical guidelines, only two thirds of all health care providers were fully adherent to guidelines. Gynecologic oncologists were more likely to follow surgical guidelines compared with general ob-gyns and more likely to diagnose occult neoplasia despite similar patient populations. Rates of risk-reducing surgery will likely continue to increase as genetic testing becomes more widespread, highlighting the importance of health care provider education for this procedure. Centralized care or referral to subspecialists for risk-reducing salpingo-oophorectomy may be warranted.
Identifiants
pubmed: 31403600
doi: 10.1097/AOG.0000000000003421
pmc: PMC6820850
mid: NIHMS1055625
pii: 00006250-201909000-00013
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
520-526Subventions
Organisme : NICHD NIH HHS
ID : K12 HD055887
Pays : United States
Références
N Engl J Med. 2002 May 23;346(21):1616-22
pubmed: 12023993
Am J Obstet Gynecol. 2006 Jun;194(6):1702-9
pubmed: 16731090
Am J Surg Pathol. 2006 Feb;30(2):230-6
pubmed: 16434898
Am J Obstet Gynecol. 2013 Nov;209(5):409-14
pubmed: 23583217
Breast Cancer Res Treat. 2010 Nov;124(1):195-203
pubmed: 20180014
J Clin Oncol. 2007 Apr 10;25(11):1329-33
pubmed: 17416853
J Clin Oncol. 2008 Mar 10;26(8):1331-7
pubmed: 18268356
J Clin Oncol. 2014 May 20;32(15):1547-53
pubmed: 24567435
J Clin Oncol. 2014 Oct 10;32(29):3275-83
pubmed: 25199754
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
Cancer Prev Res (Phila). 2018 Nov;11(11):697-706
pubmed: 30232083
Int J Gynecol Cancer. 2011 Jul;21(5):846-51
pubmed: 21670699